CFGS
LABU icon

Concourse Financial Group Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Concourse Financial Group Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$28.7K – 2212
2020
Q2 		$30K Buy
+25
New +$21.7K ﹤0.01% 1149

Other funds holding LABU

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $647M AUM 89.3% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return

Concourse Financial Group Securities's LABU Position: Q3 2020 in Review

Concourse Financial Group Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2020, closing a stake of 25 shares — an estimated $28.7K sold.

Concourse Financial Group Securities first reported a position in LABU in Q2 2020 and held it in 1 quarter. The position peaked at $30K in Q2 2020. 20 funds tracked by Wall St. Rank hold LABU as of Q3 2020.

  • Concourse Financial Group Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2020 after selling out during the quarter.
  • Concourse Financial Group Securities sold 25 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2020, an estimated $28.7K.
  • Concourse Financial Group Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2020 and held it in 1 quarter.
  • Concourse Financial Group Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $30K in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2020.

Based on Concourse Financial Group Securities's 13F filing for Q3 2020, filed 13 Nov 2020.